Arteries Inc. , a privately held company dedicated to deep learning in medical imaging, today announced the final closure of its Series A funding, bringing total Series A funding to more than $12 million. GE Ventures, the Stanford-StartX Fund (co-founded by StartX accelerator, Stanford University and Stanford Health Care) and Norwich Ventures join Emergent Medical Partners who lead the round, with additional participation from existing investors Asset Management Ventures, AME Cloud Ventures and Morado Ventures. Arterys plans to use the proceeds to expand the business operations of the company’s visualization and quantification algorithm for medical imaging.
‘This funding includes leading healthcare organizations that recognize the game-changing value of our solution to revolutionize medical imaging and improve patient care,’ said Fabien Beckers, Ph.D. D. D. Founder and Chief Executive Officer of Arterys ‘We plan to staff strategically as we expand our commercial presence in both the United States and Europe, while at the same time applying our medical imaging solutions beyond cardiac care in neurology and oncology. ”
Although cardiovascular disease is the leading cause of death in the United States, there is no reliable non-invasive comprehensive diagnostic tool available. The non-invasive standard of care is an echocardiogram, which is a validated first-line diagnosis, but lacks the accuracy of blood flow. Alternatives to more precise quantitative measures remain expensive, time-consuming and/or invasive.
Arterys has developed revolutionary diagnostic software that connects to a standard MRI machine to enable non-invasive, accurate blood flow quantification by quickly leveraging the latest cloud computing technology. Patients undergo a simple MRI scan of the chest within 10 minutes and data is sent to a secure, HIPA-compliant cloud server for computational analysis via a simple web browser.
Using deep learning and artificial intelligence, the Arterys solution allows clinicians to interact with the data, approve the quantitative clinical analysis suggested by the software in a few minutes to evaluate patients with cardiovascular disease. Specific uses of this software include the assessment of patients with structural heart disease, congenital heart disease, carotid/neurovascular and renal vascular disease.
The ArterysTM system is available for research use in leading centers around the world and will be commercially available to thousands of installed and new GE Healthcare MRI scanners worldwide through the ViosWorks* application in the fall of 2016.
*Not commercially available yet
About the Platform ArterysTM
ArterysTM is a cloud-based medical imaging, machine learning platform designed to deliver ultra-fast visualization and quantification using automatic analysis. The system has received its CE mark and market clearance from the U Oh, S Food and Drug Administration, March 2014 The Arterys platform is currently being used for research in a number of leading hospitals in the United States and Europe and will be available through ViosWorks in up to 7,000 GE magnetic resonance imaging machines in the second half of 2016. To view the videos of the ArterysTM system, click here and click here.
About Arteries Inc
Arteries Inc. Opens medical imagery to the power of the cloud Arterys has developed 4D Flow technology, which generates accurate measurements of blood flow non-invasively and non-radiatively anywhere in the body. The company’s medical imaging platform SaaS analytics combines the best in cloud computing and machine learning to improve diagnostic and therapeutic decision making. This is the first solution that allows physicians to visualize and analyze 3D blood flow inside the heart with automatic, interactive reporting. Arterys plans to use its ultra-fast visualization, unlimited file size, automated real-time quantification, peer-based learning algorithms, and time savings for other medical applications. By making imaging diagnoses quantitative, smart and available, Arterys seeks to improve the lives of millions of patients. Please visit www for more information. Arteries Come on, Follow Arterys on Twitter at @ArterysInc on https://twitter Come/ArterysInc
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/Arterys/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
